JP2020509036A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509036A5
JP2020509036A5 JP2019547373A JP2019547373A JP2020509036A5 JP 2020509036 A5 JP2020509036 A5 JP 2020509036A5 JP 2019547373 A JP2019547373 A JP 2019547373A JP 2019547373 A JP2019547373 A JP 2019547373A JP 2020509036 A5 JP2020509036 A5 JP 2020509036A5
Authority
JP
Japan
Prior art keywords
density lipoprotein
patient
high density
composition
lipoprotein composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019547373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020509036A (ja
Filing date
Publication date
Priority claimed from US15/876,808 external-priority patent/US20190021674A1/en
Application filed filed Critical
Priority claimed from PCT/US2018/020502 external-priority patent/WO2018160868A1/en
Publication of JP2020509036A publication Critical patent/JP2020509036A/ja
Publication of JP2020509036A5 publication Critical patent/JP2020509036A5/ja
Priority to JP2023007457A priority Critical patent/JP2023071648A/ja
Pending legal-status Critical Current

Links

JP2019547373A 2017-03-01 2018-03-01 アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 Pending JP2020509036A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023007457A JP2023071648A (ja) 2017-03-01 2023-01-20 アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201762465262P 2017-03-01 2017-03-01
US62/465,262 2017-03-01
US201762516100P 2017-06-06 2017-06-06
US62/516,100 2017-06-06
US201762537581P 2017-07-27 2017-07-27
US62/537,581 2017-07-27
US15/876,808 2018-01-22
US15/876,808 US20190021674A1 (en) 2017-01-23 2018-01-22 Methods for Treating Cholesterol-Related Diseases
PCT/US2018/020502 WO2018160868A1 (en) 2017-03-01 2018-03-01 Methods for prophylactically preventing, slowing the progression of, or treating alzheimer's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023007457A Division JP2023071648A (ja) 2017-03-01 2023-01-20 アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法

Publications (2)

Publication Number Publication Date
JP2020509036A JP2020509036A (ja) 2020-03-26
JP2020509036A5 true JP2020509036A5 (enExample) 2021-03-25

Family

ID=67682480

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019547373A Pending JP2020509036A (ja) 2017-03-01 2018-03-01 アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法
JP2023007457A Pending JP2023071648A (ja) 2017-03-01 2023-01-20 アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023007457A Pending JP2023071648A (ja) 2017-03-01 2023-01-20 アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法

Country Status (5)

Country Link
EP (1) EP3589272A4 (enExample)
JP (2) JP2020509036A (enExample)
CN (1) CN110545797A (enExample)
AU (1) AU2018226803A1 (enExample)
CA (1) CA3053491A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019264938A1 (en) * 2018-05-11 2020-12-03 Hdl Therapeutics, Inc. Methods for prophylactically preventing, slowing the progression of, or treating cerebral amyloid angiopathy, alzheimer's disease and/or acute stroke
CN116662835A (zh) * 2022-02-18 2023-08-29 医疗研究开发有限公司 分层方法以及分层装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534243A4 (en) * 2002-08-26 2008-08-13 Lipid Sciences Inc TREATMENT OF ALZHEIMER WITH ENTLIPIDED PROTEIN PARTICLES
PT1641421T (pt) * 2003-07-03 2019-03-27 Hdl Therapeutics Inc Métodos e dispositivos para criar derivados de partículas de hdl com conteúdo de lípidos reduzido
PT2089417E (pt) * 2006-10-12 2015-04-14 Bhi Ltd Partnership Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico
US8071100B2 (en) * 2007-02-23 2011-12-06 The Unites States of America as represented by the Secretary of Department of Health and Human Services Monoclonal antibodies that neutralize anthrax toxins
EP2152309B1 (en) * 2007-05-14 2013-07-10 Medtronic, Inc. Methods and device to neutralize soluble toxic agents in the brain

Similar Documents

Publication Publication Date Title
WO2009151646A3 (en) Non-invasive diagnostic agents and methods of diagnosing infectious disease
JP2020513032A5 (enExample)
CN109310769A (zh) 用rxr激动剂与甲状腺激素的组合的自身免疫疾病的治疗
JP2020509036A5 (enExample)
Vander Doelen et al. Conservative management of Morel-Lavallée lesion: a case study
Smyth et al. An unusual delayed complication of inferior alveolar nerve block
Peress et al. Combined myelopathy and radiculoneuropathy with malignant lymphoproliferative disease
Ramesh et al. Systemic involvement in leprosy
Muthaffar et al. Acute hemiplegia as a rare presentation of infantile Guillain-Barre syndrome
Cheng et al. Acute asymmetric sensorimotor variant of chronic inflammatory demyelinating polyneuropathy triggered by mRNA-1273 COVID-19 vaccination
Masmoudi et al. Diabetes-related distress and its associated factors among patients with type 2 diabetes mellitus in Tunisia
Zhao et al. Nitrous Oxide Induced Subacute Combined Degeneration
Mathé et al. Greffes de moelle osseuse après irradiation totale chez des souris leucémiques suivies de l'administration d'un produit antimitotique
Vázquez et al. When magic happens. An interesting study of symptoms
Ibrahim et al. Neuromyotonia (Isaacs’ Syndrome) in a patient with shistosomaiasis with good response to plasmapharesis: A case report
Zushi et al. Osteonecrosis of the jaw in an AIDS patient: a case report
Kurohara et al. A neuroendocrine tumor in the maxilla
Pisciotta et al. P4. 15 A novel GDAP1 mutation in autosomal dominant Charcot-Marie-Tooth disease
YALINAY DİKMEN et al. A case with cramp-fasciculation syndrome
Lee Unilateral periodic limb movements during sleep as a prodromal stroke symptom: a case report
Sharratt et al. G132 Co-morbidities in children and young people with chronic idiopathic pain syndrome
Leci et al. Effects Of SC Treprostinil On Top Of Double Oral Combination Therapy In Patients With Pulmonary Arterial Hypertensione (PAH) And Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Stoehr Potent anti-tremor effects of lacosamide in a rat model for essential tremor: P1361
Edwards et al. Reply: Evidence against volume conduction to explain normal MEPs in muscles with low motor power in SCI
Moneghan et al. The Effects of Stretching on Vertical Jump Performance: 1706: Board# 143 June 2 3: 30 PM-5: 00 PM